Endostatin/Collagen XVIII is increased in cerebrospinal fluid after severe traumatic brain injury

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Chen, Hao ^a   Xue, Li Xia ^a   Cao, He Li ^a   Chen, Shi Wen ^a   Guo, Yan ^a   Gao, Wen Wei ^a   Ju, Shi Ming ^a   Tian, Heng Li ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 18; ENDOSTATIN;

ADULT; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GLASGOW COMA SCALE; HUMAN; MALE; TRAUMATIC BRAIN INJURY; AGED; BRAIN INJURY; CEREBROSPINAL FLUID; ENZYME LINKED IMMUNOSORBENT ASSAY; ISOLATION AND PURIFICATION; MIDDLE AGED; PATHOPHYSIOLOGY; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC;

AGED; BRAIN INJURIES; COLLAGEN TYPE XVIII; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLASGOW COMA SCALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; ROC CURVE;

EID: 84884829798     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/402375     Document Type: Article

References (20)

1. Pandya N. M., Dhalla N. S., Santani D. D., Angiogenesis-a new target for future therapy. Vascular Pharmacology 2006 44 5 265 274 2-s2.0-33646557055 10.1016/j.vph.2006.01.005
2. Sköld M. K., Risling M., Holmin S., Inhibition of vascular endothelial growth factor receptor 2 activity in experimental brain contusions aggravates injury outcome and leads to early increased neuronal and glial degeneration. European Journal of Neuroscience 2006 23 1 21 34 2-s2.0-33644949372 10.1111/j.1460-9568.2005.04527.x
3. Morgan R., Kreipke C. W., Roberts G., Bagchi M., Rafols J. A., Neovascularization following traumatic brain injury: possible evidence for both angiogenesis and vasculogenesis. Neurological Research 2007 29 4 375 381 2-s2.0-34547581940 10.1179/016164107X204693 (Pubitemid 47196056)
4. Nag S., Takahashi J. L., Kilty D. W., Role of vascular endothelial growth factor in blood-brain barrier breakdown and angiogenesis in brain trauma. Journal of Neuropathology and Experimental Neurology 1997 56 8 912 921 2-s2.0-0030755396 (Pubitemid 27329112)
5. Nag S., Eskandarian M. R., Davis J., Eubanks J. H., Differential expression of vascular endothelial growth factor-A (VEGF-A) and VEGF-B after brain injury. Journal of Neuropathology and Experimental Neurology 2002 61 9 778 788 2-s2.0-0036713708 (Pubitemid 35001350)
6. Italiano J. E. Jr., Richardson J. L., Patel-Hett S., Battinelli E., Zaslavsky A., Short S., Ryeom S., Folkman J., Klement G. L., Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet granules and differentially released. Blood 2008 111 3 1227 1233 2-s2.0-38949178835 10.1182/blood-2007-09-113837 (Pubitemid 351213404)
7. Shore P. M., Jackson E. K., Wisniewski S. R., Clark R. S. B., Adelson P. D., Kochanek P. M., Robertson C. S., Proctor M. R., Scott R. M., Sutton L. N., Aryan H. E., Levy M. L., Vascular endothelial growth factor is increased in cerebrospinal fluid after traumatic brain injury in infants and children. Neurosurgery 2004 54 3 605 612 2-s2.0-10744225620 (Pubitemid 38298732)
8. Sköld M. K., von Gertten C., Sandberg-Nordqvist A. C., Mathiesen T., Holmin S., VEGF and VEGF receptor expression after experimental brain contusion in rat. Journal of Neurotrauma 2005 22 3 353 367 2-s2.0-15944411731 10.1089/neu.2005.22.353 (Pubitemid 40434684)
9. Gong D., Zhang S., Liu L., Dong J., Guo X., Hao M., Tu Y., Diao Y., Zhang J., Dynamic changes of vascular endothelial growth factor and angiopoietin-1 in association with circulating endothelial progenitor cells after severe traumatic brain injury. Journal of Trauma-Injury, Infection and Critical Care 2011 70 6 1480 1484 2-s2.0-79958784438 10.1097/TA.0b013e31821ac9e1
10. Mueller C. A., Schluesener H. J., Fauser U., Conrad S., Schwab J. M., Lesional expression of the endogenous angiogenesis inhibitor endostatin/collagen XVIII following traumatic brain injury (TBI). Experimental Neurology 2007 208 2 228 237 2-s2.0-36048944802 10.1016/j.expneurol.2007.07.020 (Pubitemid 350101500)
11. Zhang Z. Y., Zhang Z., Fauser U., Artelt M., Burnet M., Schluesener H. J., Dexamethasone transiently attenuates up-regulation of endostatin/collagen XVIII following traumatic brain injury. Neuroscience 2007 147 3 720 726 2-s2.0-34250897292 10.1016/j.neuroscience.2007.04.052 (Pubitemid 46990648)
12. Deininger M. H., Meyermann R., Schluesener H. J., Endostatin/collagen XVIII accumulates in patients with traumatic brain injury. Journal of Neurotrauma 2006 23 7 1103 1110 2-s2.0-33746719298 10.1089/neu.2006.23.1103 (Pubitemid 44162715)
13. The Brain Trauma Foundation, Guidelines for the management of severe head injury. Introduction. Journal of Neurotrauma 1996 13 11 643 645 10.1089/neu.1996.13.643
14. Teasdale G. M., Pettigrew L. E. L., Wilson J. T. L., Murray G., Jennett B., Analyzing outcome of treatment of severe head injury: a review and update on advancing the use of the Glasgow Outcome Scale. Journal of Neurotrauma 1998 15 8 587 597 2-s2.0-0031707406 (Pubitemid 28413052)
15. Wenzel D., Schmidt A., Reimann K., Hescheler J., Pfitzer G., Bloch W., Fleischmann B. K., Endostatin, the proteolytic fragment of collagen XVIII, induces vasorelaxation. Circulation Research 2006 98 9 1203 1211 2-s2.0-33745049511 10.1161/01.RES.0000219899.93384.ed (Pubitemid 43948107)
16. Seppinen L., Sormunen R., Soini Y., Elamaa H., Heljasvaara R., Pihlajaniemi T., Lack of collagen XVIII accelerates cutaneous wound healing, while overexpression of its endostatin domain leads to delayed healing. Matrix Biology 2008 27 6 535 546 2-s2.0-48149090563 10.1016/j.matbio.2008.03.003
17. Bloch W., Huggel K., Sasaki T., Grose R., Bugnon P., Addicks K., Timpl R., Werner S., The angiogenesis inhibitor endostatin impairs blood vessel maturation during wound healing. The FASEB Journal 2000 14 15 2373 2376 2-s2.0-0034575632
18. Mueller C. A., Conrad S., Schluesener H. J., Pietsch T., Schwab J. M., Spinal cord injury-induced expression of the antiangiogenic endostatin/collagen XVIII in areas of vascular remodelling. Journal of Neurosurgery 2007 7 2 205 214 2-s2.0-34547650849 10.3171/SPI-07/08/205 (Pubitemid 47219755)
19. Benezra R., Rafii S., Endostatin's endpoints-deciphering the endostatin antiangiogenic pathway. Cancer Cell 2004 5 3 205 206 2-s2.0-1642462840 10.1016/S1535-6108(04)00057-1 (Pubitemid 38402111)
20. 2 and phosphatase inhibitors activate endothelial cell ERK1/2 MAP-kinase. Microvascular Research 2005 69 1-2 36 44 2-s2.0-15744393966 10.1016/j.mvr.2004.11.003 (Pubitemid 40410466)